ABUS

#2549
Arbutus Biopharma Corporation Common Stock
4.58 USD
+5.29%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
4.57
4.60
Intervallo Annuale
2.94
5.10
Variazione giornaliera
+5.29%
Variazione Mensile
+6.51%
Variazione di 6 mesi
+1.78%
Variazione Annuale
+44.48%
Chiusura Precedente
4.35
Apertura
4.58
Bid
Ask
Minimo
4.57
High
4.60
Volume
143
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 895.29 M
  • Employee 19
  • Founded 2007
  • CEO William H. Collier
  • Website www.arbutusbio.com
  • Headquarter British Columbia, Canada
  • FIGI BBG000RR8V85
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-28.29
Rapporto prezzo/fatturato
65.44

Arbutus Biopharma Corporation

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.

Notizie